Unlike docetaxel, which is a cytotoxic drug targeting all proliferative cells, ISA-2011B inhibits tumor growth and promotes apoptosis by blocking PI3K/AKT, a key cancer survival and invasion pathway in MDA-MB-231 cells. The gene discussed is AKT1; the disease is cancer.